254 related articles for article (PubMed ID: 28110463)
1. Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.
Golovastova MO; Korolev DO; Tsoy LV; Varshavsky VA; Xu WH; Vinarov AZ; Zernii EY; Philippov PP; Zamyatnin AA
Curr Urol Rep; 2017 Jan; 18(1):3. PubMed ID: 28110463
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic and prognostic markers of renal cell carcinoma].
Spadaccino F; Netti GS; Rocchetti MT; Castellano G; Stallone G; Ranieri E
G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281759
[TBL] [Abstract][Full Text] [Related]
3. The cancer-retina antigen recoverin as a potential biomarker for renal tumors.
Golovastova MO; Tsoy LV; Bocharnikova AV; Korolev DO; Gancharova OS; Alekseeva EA; Kuznetsova EB; Savvateeva LV; Skorikova EE; Strelnikov VV; Varshavsky VA; Vinarov AZ; Nikolenko VN; Glybochko PV; Zernii EY; Zamyatnin AA; Bazhin AV; Philippov PP
Tumour Biol; 2016 Jul; 37(7):9899-907. PubMed ID: 26813565
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of morphologically unclassified renal cell carcinoma with electron microscopy and novel renal markers: implications for tumor reclassification.
Talento R; Hewan-Lowe K; Yin M
Ultrastruct Pathol; 2013 Feb; 37(1):70-6. PubMed ID: 23383617
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
6. Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.
Osman WM; Youssef NS
Int J Clin Exp Pathol; 2015; 8(7):8165-77. PubMed ID: 26339385
[TBL] [Abstract][Full Text] [Related]
7. [Biomarker for molecular targeting therapy against renal cell carcinoma].
Mizuno R; Oya M
Gan To Kagaku Ryoho; 2012 Jan; 39(1):39-42. PubMed ID: 22454982
[No Abstract] [Full Text] [Related]
8. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.
Eichelberg C; Junker K; Ljungberg B; Moch H
Eur Urol; 2009 Apr; 55(4):851-63. PubMed ID: 19155123
[TBL] [Abstract][Full Text] [Related]
9. Kidney cancer: not a single disease.
Pospihalj B; Zamparese R; Mazzucchelli R; Morichetti D
Anal Quant Cytol Histol; 2007 Dec; 29(6):377-9. PubMed ID: 18228653
[No Abstract] [Full Text] [Related]
10. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase IX/G250/MN: a molecule too good to be true?
Oosterwijk E
BJU Int; 2008 Mar; 101(5):527-8. PubMed ID: 18257853
[No Abstract] [Full Text] [Related]
12. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
Gokden N; Gokden M; Phan DC; McKenney JK
Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic prognostic indicators for renal cell carcinoma.
Delahunt B
Semin Diagn Pathol; 1998 Feb; 15(1):68-76. PubMed ID: 9503507
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
15. Current trends in the molecular classification of renal neoplasms.
Young AN; Master VA; Amin MB
ScientificWorldJournal; 2006 Dec; 6():2505-18. PubMed ID: 17619725
[TBL] [Abstract][Full Text] [Related]
16. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
[TBL] [Abstract][Full Text] [Related]
17. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma.
Lin F; Zhang PL; Yang XJ; Shi J; Blasick T; Han WK; Wang HL; Shen SS; Teh BT; Bonventre JV
Am J Surg Pathol; 2007 Mar; 31(3):371-81. PubMed ID: 17325478
[TBL] [Abstract][Full Text] [Related]
18. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
[TBL] [Abstract][Full Text] [Related]
19. Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.
Alfaro CM; Jarmusch AK; Pirro V; Kerian KS; Masterson TA; Cheng L; Cooks RG
Anal Bioanal Chem; 2016 Aug; 408(20):5407-14. PubMed ID: 27206411
[TBL] [Abstract][Full Text] [Related]
20. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up.
Alderman MA; Daignault S; Wolf JS; Palapattu GS; Weizer AZ; Hafez KS; Kunju LP; Wu AJ
Hum Pathol; 2016 Sep; 55():1-10. PubMed ID: 27085554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
